Yehuda Handelsman to Diabetic Nephropathies
This is a "connection" page, showing publications Yehuda Handelsman has written about Diabetic Nephropathies.
Connection Strength
0.569
-
Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study. Diabetes Care. 2014 Oct; 37(10):2723-30.
Score: 0.432
-
How does CKD affect HbA1c? J Diabetes. 2018 Apr; 10(4):270.
Score: 0.137